Shendong Yuan

668 citations

20 papers · 524 indexed · h-index 11

Co-authors: Judi Bryant Brad O. Buckman Marc Whitlow Marc Adler Hui Ding Zhan‐Ting Li Guo‐Zhen Ji Mingdeng Wei
Topics: Signaling Pathways in Disease (4 papers)Computational Drug Discovery Methods (3 papers)Antiplatelet Therapy and Cardiovascular Diseases (3 papers)
Cited by: Organic Chemistry Spectroscopy Cancer Research
Journals: Journal of Biological Chemistry Biochemistry The Journal of Organic Chemistry
Partner nations: United States China Saudi Arabia

In The Last Decade

Shendong Yuan

20 papers receiving 509 citations

Peers

Countries citing papers authored by Shendong Yuan

Since Specialization

Citations

This map shows the geographic impact of Shendong Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shendong Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shendong Yuan more than expected).

Fields of papers citing papers by Shendong Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shendong Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shendong Yuan. The network helps show where Shendong Yuan may publish in the future.

Co-authorship network of co-authors of Shendong Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Shendong Yuan. A scholar is included among the top collaborators of Shendong Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shendong Yuan. Shendong Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NLRP3 inhibition by VTX3232 tempers inflammation resulting in reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice 2025 ·Molecular Metabolism ·Jennyfer Bultinck,Shendong Yuan,Ludovico Cantuti‐Castelvetri,(unknown),(unknown),James W. Collins,(unknown),Christina A. Christianson,John M. Nuss,Kathleen M. Ogilvie	1
2	43073 Pharmacokinetics, Safety and Pharmacodynamics of VTX2735, A Potent and Selective NLRP3 Inhibitor, In Healthy Adult Volunteers 2023 ·Journal of the American Academy of Dermatology ·William J. Sandborn,(unknown),Kathleen M. Ogilvie,Fei Liu,Snehal Naik,(unknown),Shendong Yuan,John M. Nuss	2
3	Total Synthesis of Covalent Cysteine Protease Inhibitor N-Desmethyl Thalassospiramide C and Crystallographic Evidence for Its Mode of Action 2019 ·Organic Letters ·(unknown),Karen Chen,Artur K. Mailyan,Jeffrey J. Jackson,Brad O. Buckman,(unknown),Shendong Yuan,(unknown),Shawn Misialek,Marc J. Adler,M. Blaesse,(unknown),Armen Zakarian	3
4	Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis 2018 ·Bioorganic & Medicinal Chemistry Letters ·Imadul Islam,Shendong Yuan,Christopher W. West,Marc Adler,Ulrich Bothe,Judi Bryant,(unknown),(unknown),(unknown),(unknown),Elena Ho,David R. Light,Cornell Mallari,John Morser,Gary B. Phillips,Caralee Schaefer,Drew A. Sukovich,Marc Whitlow,(unknown),Brad O. Buckman	4
5	Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process 2018 ·Bioorganic & Medicinal Chemistry Letters ·Imadul Islam,Shendong Yuan,(unknown),Wei Xu,Michael M. Morrissey,Raju Mohan,(unknown),(unknown),Laura Dunning,(unknown),Babu Subramanyam,Jih‐Lie Tseng,Judi Bryant,Brad O. Buckman	7
6	Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Ying‐zi Xu,Shendong Yuan,Simeon Bowers,Roy K. Hom,(unknown),Hing L. Sham,Yong Zhu,Paul Beroza,Hu Pan,E. Brecht,Nanhua Yao,Julie C. Lougheed,Jiangli Yan,Danny Tam,Zhao Ren,Lany Ruslim,Michael P. Bova,Dean R. Artis	21
7	Development of a Novel β-Secretase Binding Assay Using the AlphaScreen Platform 2013 ·SLAS DISCOVERY ·Zhao Ren,Danny Tam,Ying‐zi Xu,(unknown),Shendong Yuan,Hing L. Sham,(unknown),Karin Regnström,Xiaohua Chen,(unknown),Michael F. Jobling,Dean R. Artis,Michael P. Bova	6
8	Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates 2013 ·Bioorganic & Medicinal Chemistry Letters ·Simeon Bowers,Ying‐zi Xu,Shendong Yuan,Gary D. Probst,Roy K. Hom,(unknown),Andrei W. Konradi,Hing L. Sham,Yong Zhu,Paul Beroza,Hu Pan,E. Brecht,Nanhua Yao,Julie C. Lougheed,Danny Tam,Zhao Ren,Lany Ruslim,Michael P. Bova,Dean R. Artis	10
9	Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Christopher W. West,Marc Adler,(unknown),(unknown),(unknown),(unknown),Elena Ho,Christoph M. Huwe,David R. Light,Gary B. Phillips,Rebecca Pulk,Drew A. Sukovich,Marc Whitlow,Shendong Yuan,Judi Bryant	11
10	Structures of potent selective peptide mimetics bound to carboxypeptidase B 2008 ·Acta Crystallographica Section D Biological Crystallography ·Marc Adler,Brad O. Buckman,Judi Bryant,Zheng Chang,(unknown),(unknown),(unknown),Imadul Islam,John Morser,Drew A. Sukovich,Christopher W. West,Shendong Yuan,Marc Whitlow	17
11	Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): In vitro effects on platelets 2008 ·Thrombosis Research ·Judi Bryant,Joseph Post,(unknown),Yixin Wang,(unknown),Sabine Schirm,Jih‐Lie Tseng,Babu Subramanyam,Brad O. Buckman,Imadul Islam,Shendong Yuan,Mark Sullivan,(unknown),John Morser	26
12	The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase 2007 ·Bioorganic & Medicinal Chemistry Letters ·Marc Whitlow,Marc Adler,David D. Davey,(unknown),(unknown),John F. Parkinson,(unknown),Mark A. Polokoff,Wei Xu,Shendong Yuan,Gary B. Phillips	6
13	Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517 2007 ·Bioorganic & Medicinal Chemistry Letters ·Imadul Islam,Greg Brown,Judi Bryant,(unknown),Monica J. Kochanny,Gary B. Phillips,Shendong Yuan,Marc Adler,Marc Whitlow,Dao Lentz,Mark A. Polokoff,James M. Wu,Jun Shen,(unknown),Elena Ho,Babu Subramanyam,Daguang Zhu,Richard I. Feldman,Damian O. Arnaiz	35
14	1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Marc Adler,David D. Davey,Elena Ho,Raju Mohan,Mark A. Polokoff,Jih‐Lie Tseng,Marc Whitlow,Wei Xu,Shendong Yuan,Gary B. Phillips	8
15	A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) – Part I: Pharmacological characterization 2007 ·Thrombosis and Haemostasis ·(unknown),Mariko Nagashima,Jon Vincelette,(unknown),(unknown),(unknown),Shendong Yuan,(unknown),Imadul Islam,(unknown),Judi Bryant,David R. Light,Ronald Vergona,(unknown),Brad O. Buckman,(unknown)	29
16	3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Imadul Islam,Judi Bryant,Karen May,Raju Mohan,Shendong Yuan,(unknown),John Morser,Lei Zhao,Ron Vergona,Kathy White,Marc Adler,Marc Whitlow,Brad O. Buckman	25
17	Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1 2005 ·Journal of Biological Chemistry ·Richard I. Feldman,James M. Wu,Mark A. Polokoff,Monica J. Kochanny,Harald Dinter,Daguang Zhu,Sandra L. Biroc,Bruno Alicke,Judi Bryant,Shendong Yuan,Brad O. Buckman,Dao Lentz,(unknown),Marc Whitlow,Marc Adler,(unknown),Zheng Chang,Damian O. Arnaiz	171
18	Crystal Structures of Potent Thiol-Based Inhibitors Bound to Carboxypeptidase B^, 2005 ·Biochemistry ·Marc Adler,Judi Bryant,Brad O. Buckman,Imadul Islam,Brent Larsen,(unknown),(unknown),Karen May,Raju Mohan,Shendong Yuan,Marc Whitlow	26
19	Self-Assembling Calix[4]arene [2]Catenanes. Preorganization, Conformation, Selectivity, and Efficiency 1999 ·The Journal of Organic Chemistry ·Zhan‐Ting Li,Guo‐Zhen Ji,Cheng‐Xue Zhao,Shendong Yuan,Hui Ding,Chen Huang,(unknown),Mingdeng Wei	110
20	The self-assembly of catenated calix[4]arenes 1998 ·Tetrahedron Letters ·Zhan‐Ting Li,Guo‐Zhen Ji,Shendong Yuan,(unknown),Hui Ding,Mingdeng Wei	6

About Shendong Yuan

Shendong Yuan is a scholar working on Toxicology, Hematology and Organic Chemistry, having authored 20 papers that have together received 524 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (4 papers), Computational Drug Discovery Methods (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). The work is most often cited by research in Organic Chemistry (176 citations), Spectroscopy (77 citations) and Cancer Research (57 citations). Shendong Yuan has collaborated with scholars based in United States, China and Saudi Arabia. Frequent co-authors include Judi Bryant, Brad O. Buckman, Marc Whitlow, Marc Adler, Hui Ding, Zhan‐Ting Li, Guo‐Zhen Ji, Mingdeng Wei, Cheng‐Xue Zhao and Chen Huang. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact